Innoviva, Inc.
INVA
$22.20
-$0.67-2.91%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 38.94% | 103.91% | 47.61% | 0.68% | 61.52% |
| Total Other Revenue | -4.57% | -12.19% | 4.98% | 0.22% | -1.04% |
| Total Revenue | 10.56% | 24.84% | 20.44% | 0.39% | 14.37% |
| Cost of Revenue | 68.16% | 298.80% | 205.04% | 25.00% | 108.28% |
| Gross Profit | 4.38% | -5.20% | -7.33% | -1.90% | 9.08% |
| SG&A Expenses | 17.99% | 2.27% | 4.39% | -4.79% | -9.58% |
| Depreciation & Amortization | 1.22% | 1.94% | 1.64% | 1.66% | 0.54% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.98% | 59.52% | 56.78% | 13.98% | 4.70% |
| Operating Income | -5.68% | -11.45% | -15.45% | -10.85% | 27.64% |
| Income Before Tax | 707.85% | 689.81% | 1,328.19% | 284.83% | -185.52% |
| Income Tax Expenses | 499.97% | 608.00% | 40.33% | 293.95% | -6.95% |
| Earnings from Continuing Operations | 500.56% | 707.36% | 7,312.04% | 283.62% | -227.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 500.56% | 707.36% | 7,312.04% | 283.62% | -227.52% |
| EBIT | -5.68% | -11.45% | -15.45% | -10.85% | 27.64% |
| EBITDA | -4.76% | -9.75% | -13.27% | -9.51% | 23.09% |
| EPS Basic | 438.69% | 575.92% | 6,610.82% | 282.64% | -228.48% |
| Normalized Basic EPS | -7.13% | -23.65% | -19.24% | -6.62% | 36.20% |
| EPS Diluted | 398.22% | 590.34% | 5,474.74% | 239.30% | -260.80% |
| Normalized Diluted EPS | -18.83% | -9.96% | -33.95% | -30.49% | 82.26% |
| Average Basic Shares Outstanding | 18.26% | 19.43% | 10.37% | 0.54% | -0.75% |
| Average Diluted Shares Outstanding | 35.31% | 1.26% | 34.97% | 35.07% | -25.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |